Journals / Dicle Tıp Dergisi / 2015 / Cilt: 42 - Sayı: 1

Erythema nodosum: The clinical and demographic characteristics of 33 patients

Eritema nodozum: 33 hastanın klinik ve demografik özellikleri

Pages
46–50
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No showed signifcant difference between clinical, laboratory, histopathological fnd - ings and treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study our aim was to determine demographic and clinical features, etiological factors, laboratory fndings and treatment regimens of patients who were diagnosed and treated with erythema nodosum.
📊
Key Findings & Data:Methods: Thirty-three patients who were clinical and histopathological diagnosed as erythema nodosum in dermatology clinic of our university, dated between 2008 and 2014, were evaluated retrospectively.
💡
Conclusion & Impact:No showed signifcant difference between clinical, laboratory, histopathological fnd - ings and treatment.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In this study our aim was to determine demographic and clinical features, etiological factors, laboratory fndings and treatment regimens of patients who were diagnosed and treated with erythema nodosum. Methods: Thirty-three patients who were clinical and histopathological diagnosed as erythema nodosum in dermatology clinic of our university, dated between 2008 and 2014, were evaluated retrospectively. Results: The study population consisted of 29 (87.9%) female and 4 (12.1%) male, with a mean age of 40.57±13.98 years (range, 11-69 years). Most patients were found in the 30-39 age range. The most frequent localization of lesions was found in the lower extremities (54.5%). Infections (30.3%) were the most common identifed etiologic factors followed by drugs (12.1%), pregnancy (6.1%), Behcet’s disease (6.1%) and sarcoidosis (3.1%). The mean duration of disease was 12.60 days. 72.7% of patients were admitted as the frst episode. The mean hospitalization time was 8.93 days. Conclusion: The etiology of erythema nodosum varies from country to country. The most common etiological factor was found idiopathic (42.4%) in our study. However, etiologic factors are similar in all studies, only showed differences in the rankings. No showed signifcant difference between clinical, laboratory, histopathological fnd - ings and treatment.

Özet

Giriş: Kliniğimizde eritema nodozum tanısıyla takip ve tedavileri yapılan hastaların demografik ve klinik özelliklerinin belirlenmesi, etiyolojik faktörlerin araştırılması, laboratuvar bulguları ve tedavi rejimlerinin değerlendirilmesi amaçlanmıştır. Yöntemler: Üniversitemiz Dermatoloji Kliniğinde 2008- 2014 yılları arasında yatırılıp takip edilen, klinik ve histopatolojik olarak eritema nodozum tanısı almış 33 hasta retrospektif olarak değerlendirildi. Bulgular: Çalışmaya alınan hastaların yaşları 11 ile 69 yıl arasında olup ortalama yaş 40,57±13,98 yıl olarak bulundu. Hastalar en çok 30-39 yaş aralığında (%33,3) saptandı. Hastaların 29u (%87,9) kadın, 4ü (%12,1) erkek idi. Lezyonların en sık yerleşim yeri %54,5 ile alt ekstremitelerde bulundu. Etiyolojide en sık %30,3 ile enfeksiyonlar (Üst solunum yolu ve idrar yolu enfeksiyonları) görülürken bunu ilaçlar (%12,1), gebelik (%6,1), Behçet hastalığı (%6,1) ve Sarkoidoz (%3,1) takip ediyordu. Ortalama hastalık süresi 12,60 gün olarak bulundu. Hastaların %72,7si ilk atak şeklinde başvurmuştu. Ortalama hastanede yatış süresi 8,93 gün olarak bulundu. Sonuç: Eritema nodozumda etiyoloji ülkeden ülkeye farklılık göstermekte olup çalışmamızda en sık idiopatik (%42,4) olarak bulundu. Ancak tüm çalışmalarda etiyolo- jik faktörler benzer olup sadece sıralamada farklılık gösteriyordu. Klinik, laboratuvar, histopatolojik bulgular ve tedavi uygulamaları arasında belirgin bir farklılık görülmedi.

🔖

Cite This Article

SULA, B., ARICA, M. (2015). Erythema nodosum: The clinical and demographic characteristics of 33 patients. Dicle Tıp Dergisi, Cilt: 42 - Sayı: 1, 46–50. https://ajindex.com/articles/349833

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Patterson JW. Panniculitis. In: Bolognia JL, Jorizzo JL, Schaffer JV editors. Dermatology. 3st ed. Elsevier 2012. p.1641-1645
  2. Mana J, Marcoval J. Erythema nodosum. Clin Dermatol 2007;25:288-294
  3. Requena L, Yus ES. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol 2001;45:163-183
  4. Gilchrist H, Patterson JW. Erythema nodosum and erythema induratum (nodular vasculitis): diagnosis and management. Dermatol Ther 2010;23:320-327
  5. Blake T, Manahan M, Rodins K. Erythema nodosum - a review of an uncommon panniculitis. Dermatol Online J 2014;20:22376
  6. Öz A, Aydoğan K, Adım ŞB, et al. Erythema Nodosum Epidemiology: 5-Years Retrospective Study. Turk J Dermatol 2012;6:87-90
  7. Adışen E, Şeker Ü, Gürer MA. Etiologic Factors in Erythema Nodosum. Türkderm 2008;42:113 -117
  8. Mert A, Ozaras R, Tabak F, et al. Erythema nodosum: an experience of 10 years. Scand J Infect Dis 2004;36:424-427
  9. Teke TA, Tanır G, Bayhan Gİ, et al. Erythema nodosum in children: evaluation of 39 patients. Turk J Pediatr 2014;56:144-149
  10. Tay YK. Erythema nodosum in Singapore. Clin Exp Dermatol 2000;25:377-380
  11. Daoud L, El Euch D, Ben Tekaya N, et al. Erythema no - dosum: profle in a Tunisian teaching hospital. Tunis Med 2007;85:1020-1024
  12. Papagrigoraki A, Gisondi P, Rosina P, et al. Erythema no - dosum: etiological factors and relapses in a retrospective cohort study. Eur J Dermatol 2010;20:773-777.